The Process of Blood Collection With a Vascular Imaging Device (VID)

December 28, 2022 updated by: özlem doğu, Sakarya University

The Effect of Using Blood Vessel Imaging Device on Pain and Satisfaction Level During the Phlebotomy Procedure

The study was planned to determine the effect of using a blood vessel imaging device (VID) and venous blood collection procedure on the pain and satisfaction level of the individual during phlebotomy. The randomized controlled experimental design study was carried out in a blood collection unit in a training and research hospital between 1-15 April 2022. The study sample was calculated as 100 people by power analysis and the method of drawing lots was applied to the groups. Data were collected using the patient identification form, visual analogue scale (VAS), and pain and satisfaction scales.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The population of the study consisted of adult individuals who benefited from polyclinic services and applied to the blood collection unit between the specified dates in a single center.

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Adapazarı
      • Sakarya, Adapazarı, Turkey, 54100
        • Sakarya Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

50 application grup 50 control grup

Description

Inclusion Criteria:

  • Individuals between the ages of 18-65,
  • Who wanted peripheral vascular access,
  • Volunteered to participate in the study,
  • Did not have any pain complaints,
  • Did not take analgesics in the last 12 hours,
  • Could be contacted,
  • Did not have obesity, dehydration, peripheral oedema, or a cancer diagnosis and did not need emergency intervention.

Exclusion Criteria:

  • Those who do not meet the criteria for admission

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Application Group
  • Filling out the pre-initiative volunteering form and sociodemographic data
  • Preparation of the individual for the transaction
  • Monitoring the vein with a vein imaging device and operating a stopwatch
  • Implementation of the initiative
  • Stopping the stopwatch at the end of the process
  • Application of VAS Pain and VAS satisfaction Scale
The process of blood collection with a vascular imaging device
Control Group
  • Filling out the pre-initiative volunteering form and sociodemographic data
  • Preparation of the individual for the transaction
  • Starting routine blood collection and starting the stopwatch
  • Implementation of the initiative
  • Stopping the stopwatch at the end of the process
  • Application of VAS Pain and VAS satisfaction Scale

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The effect of using a blood vessel imaging device on the pain of the phlebotomy procedure
Time Frame: one month
Blood vessel imaging device effective pain level
one month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The effect of using a blood vessel imaging device on satisfaction level during the phlebotomy procedure
Time Frame: one month
Blood vessel imaging device effective satisfaction level
one month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: özlem doğu, assoc. dr, Sakarya University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2022

Primary Completion (Actual)

April 15, 2022

Study Completion (Actual)

April 15, 2022

Study Registration Dates

First Submitted

October 10, 2022

First Submitted That Met QC Criteria

December 28, 2022

First Posted (Estimate)

January 10, 2023

Study Record Updates

Last Update Posted (Estimate)

January 10, 2023

Last Update Submitted That Met QC Criteria

December 28, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • Blood vessel imaging device

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Phlebotomy

Clinical Trials on The phlebotomy procedure

Subscribe